Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
3.680
+0.010 (0.27%)
At close: Jun 25, 2025, 4:00 PM
3.710
+0.030 (0.82%)
After-hours: Jun 25, 2025, 7:59 PM EDT
Akebia Therapeutics Market Cap
Akebia Therapeutics has a market cap or net worth of $966.50 million as of June 25, 2025. Its market cap has increased by 330.90% in one year.
Market Cap
966.50M
Enterprise Value
1.05B
1-Year Change
330.90%
Ranking
Category
Stock Price
$3.68
Market Cap Chart
Since March 20, 2014, Akebia Therapeutics's market cap has increased from $488.10M to $966.50M, an increase of 98.01%. That is a compound annual growth rate of 6.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2025 | 963.90M | 132.55% |
| Dec 31, 2024 | 414.50M | 77.44% |
| Dec 29, 2023 | 233.60M | 120.17% |
| Dec 30, 2022 | 106.10M | -73.17% |
| Dec 31, 2021 | 395.40M | -2.30% |
| Dec 31, 2020 | 404.70M | -46.16% |
| Dec 31, 2019 | 751.70M | 138.26% |
| Dec 31, 2018 | 315.50M | -55.11% |
| Dec 29, 2017 | 702.90M | 76.17% |
| Dec 30, 2016 | 399.00M | 0.81% |
| Dec 31, 2015 | 395.80M | 67.15% |
| Dec 31, 2014 | 236.80M | -51.49% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.73B |
| Johnson & Johnson | 360.41B |
| AbbVie | 327.31B |
| Novo Nordisk | 326.28B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 231.38B |
| Novartis AG | 227.54B |
| AstraZeneca | 217.06B |